Cover Image

Anti-Breast Cancer Activities of 8-Hydroxydaidzein by Targeting Breast Cancer Stem-Like Cells

Purpose: Cancer stem cells (CSCs) play an important role in various stages of cancer development and therapy refractoriness. 8-Hydroxydaidzein (8-OHD) has revealed anti-cancer activity in different tumors. Accordingly, we aimed to assess the effects of 8-OHD on the suppression of breast cancer stem-...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sadegh Rajabi (Author), Maryam Shojaee (Author), Ali Malmir (Author), Mostafa Rezaei Tavirani (Author), Shokoofe Noori (Author)
Format:	Book
Published:	Frontiers Media S.A., 2020-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Attenuation of Inflammatory Responses in Breast and Ovarian Cancer Cells by a Novel Chalcone Derivative and Its Increased Potency by Curcumin
by: Mitra Nourbakhsh, et al.
Published: (2023)

Targeting cancer stem cell plasticity in triple-negative breast cancer
by: Zhengwang Guo, et al.
Published: (2023)

Nanomedicine-mediated therapies to target breast cancer stem cells
by: Lili He, et al.
Published: (2016)

Identification of two cancer stem cell-like populations in triple-negative breast cancer xenografts
by: Jun Nakayama, et al.
Published: (2022)

Britannin suppresses MCF-7 breast cancer cell growth by inducing apoptosis and inhibiting autophagy
by: Sadegh Rajabi, et al.
Published: (2024)

Naringenin and cryptotanshinone shift the immune response towards Th1 and modulate T regulatory cells via JAK2/STAT3 pathway in breast cancer
by: Shokoofe Noori, et al.
Published: (2022)

Targeting ferroptosis in breast cancer
by: Zhaoqing Li, et al.
Published: (2020)

Weak Anti-inflammatory and Anti-cancer Properties of Saffron
by: Mohammad Hossein Heidari, et al.
Published: (2020)

Delivery of Protein Kinase A by CRISPRMAX and Its Effects on Breast Cancer Stem-Like Properties
by: Jun-Nian Zhou, et al.
Published: (2020)

Molecular Docking as a Therapeutic Approach for Targeting Cancer Stem Cell Metabolic Processes
by: Babak Arjmand, et al.
Published: (2022)

Therapy-resistant breast cancer in focus: Clinically relevant mitigation by flavonoids targeting cancer stem cells
by: Alena Mazurakova, et al.
Published: (2023)

GEMIN4, a potential therapeutic targets for patients with basal-like subtype breast cancer
by: Liang Wu, et al.
Published: (2023)

Corrigendum: Molecular Docking as a Therapeutic Approach for Targeting Cancer Stem Cell Metabolic Processes
by: Babak Arjmand, et al.
Published: (2022)

Anti-cancer effect and potential microRNAs targets of ginsenosides against breast cancer
by: Meiling Fan, et al.
Published: (2022)

The Anti-Cancer Effects of Mitochondrial-Targeted Triphenylphosphonium-Resveratrol Conjugate on Breast Cancer Cells
by: Lingling Jiang, et al.
Published: (2022)

Neutrophils as potential therapeutic targets for breast cancer
by: Yi-Ting Gong, et al.
Published: (2023)

Trop2-targeted therapy in breast cancer
by: Yixuan Hu, et al.
Published: (2024)

Proteolysis-targeting chimeras and their implications in breast cancer
by: Angeles C. Tecalco-Cruz, et al.
Published: (2021)

Targeting Engineered Nanoparticles for Breast Cancer Therapy
by: Kumar Ganesan, et al.
Published: (2021)

Cancer stem cells are new vistas for predicting the course of breast cancer
by: E. A. Maslyukova, et al.
Published: (2015)

The Breast Cancer Stem Cells Traits and Drug Resistance
by: Qinghui Zheng, et al.
Published: (2021)

Targeted Fluoromagnetic Nanoparticles for Imaging of Breast Cancer MCF-7 Cells
by: Javid Shahbazi, et al.
Published: (2013)

Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond
by: Jianwei Feng, et al.
Published: (2022)

Evaluation of the Effect of Mesenchymal Stem Cells on Breast Cancer Migration and Metastasis: A Systematic Review and Meta-analysis
by: Pezhman Ghadami, et al.
Published: (2023)

Effects of BYL-719 (alpelisib) on human breast cancer stem cells to overcome drug resistance in human breast cancer
by: Leinan Yu, et al.
Published: (2024)

Triple-negative Breast Cancer Therapy Using RNA Nanoparticles Targeting Stem Cell Markers with Anti-miRNA: A Systematic Review and Meta-Analysis
by: Maryam Fathi, et al.
Published: (2023)

Curcumin: a calixarene derivative micelle potentiates anti-breast cancer stem cells effects in xenografted, triple-negative breast cancer mouse models
by: Wei Chen, et al.
Published: (2017)

Identification of potential therapeutic target of naringenin in breast cancer stem cells inhibition by bioinformatics and in vitro studies
by: Adam Hermawan, et al.
Published: (2021)

Integrative Bioinformatics Analysis Reveals Possible Target and Mechanism of Ellipticine Against Breast Cancer Stem Cells.
by: Adam Hermawan, et al.
Published: (2021)

The Effect of Telephone Counseling and Education on Breast Cancer Screening in Family Caregivers of Breast Cancer Patients
by: Khadijeh Nasiriani, et al.
Published: (2017)

Drug delivery using nanoparticles for cancer stem-like cell targeting
by: Bing eLu, et al.
Published: (2016)

Breast Cancer and Breast Reconstruction
Published: (2020)

Targeting New Pathways and Cell Death in Breast Cancer
Published: (2012)

Fundamental Considerations of Targeted Drug Therapies for Breast Cancer
by: Ileana Castillo-Tobías, et al.
Published: (2023)

Emerging potentials of nanotherapeutics in breast cancer microenvironment targeting
by: Vaishnavi Gadi, et al.
Published: (2022)

Targeting the stimulator of interferon genes (STING) in breast cancer
by: Ma Ying-Rui, et al.
Published: (2023)

Targeting HER 1 and 2 in breast cancer with lapatinib
by: Gerald M. Higa
Published: (2011)

Targeting HER 1 and 2 in breast cancer with lapatinib
by: Gerald M. Higa
Published: (2011)

DNA damage targeted therapy for advanced breast cancer
by: Vanessa Patel, et al.
Published: (2024)

Thymoquinone inhibited vasculogenic capacity and promoted mesenchymal-epithelial transition of human breast cancer stem cells
by: Sanya Haiaty, et al.
Published: (2021)